India’s pharmaceutical industry is witnessing a surge in global partnerships, with countries such as Switzerland, Uzbekistan, ...
India’s Dr Reddy’s Laboratories (NYSE: RDY) has received a fresh Form 483 from the US Food and Drug Administration, keeping regulatory scrutiny fixed on one of its biologics manufacturing sites just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results